Caring Agency Seeks Stable Partner For FOB User Fee Negotiations
FDA's negotiations with the generics industry on ANDA user fees are just getting off the ground, but the agency is already gearing up for the next user fee frontier: biosimilars.
FDA's negotiations with the generics industry on ANDA user fees are just getting off the ground, but the agency is already gearing up for the next user fee frontier: biosimilars.